Company · CIK 0001630627 · SIC 3841 — Surgical & Medical Instruments & Apparatus · Nasdaq
TREACE MEDICAL CONCEPTS, INC. · TMCI
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 20, 2026 PForm 4 → | Aug 24, 5:00 pm EDT | John T. TreaceChief Executive Officer, Director, 10% Owner | 55,944 | $4.41 | $246,654 | 7,404,383 | +0.76% | |
| Aug 9, 2026 FForm 4 → | Aug 12, 6:00 pm EDT | Sean F. ScanlanChief Innovation Officer | 9,814 | — | — | 679,863 | — | late |
| Aug 9, 2026 FForm 4 → | Aug 12, 5:30 pm EDT | Mark HairChief Financial Officer | 37,102 | — | — | 914,900 | — | late |
| Aug 9, 2026 FForm 4 → | Aug 12, 5:30 pm EDT | Scot Michael ElderChief Legl & Comp Off, CorpSec | 16,253 | — | — | 778,683 | — | late |
| Jun 10, 2026 PForm 4/A → | Jun 12, 9:26 am EDT | John T. TreaceChief Executive Officer, Director, 10% Owner | 24,606 | $4.03 | $99,196 | 7,348,439 | +0.34% | |
| Jun 10, 2026 PForm 4 → | Jun 11, 4:52 pm EDT | John T. TreaceChief Executive Officer, Director, 10% Owner | 52,317 | $4.03 | $210,968 | 7,376,150 | +0.71% | amended |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.